NO934382L - Suppressor T-cell hybridoma - Google Patents

Suppressor T-cell hybridoma

Info

Publication number
NO934382L
NO934382L NO934382A NO934382A NO934382L NO 934382 L NO934382 L NO 934382L NO 934382 A NO934382 A NO 934382A NO 934382 A NO934382 A NO 934382A NO 934382 L NO934382 L NO 934382L
Authority
NO
Norway
Prior art keywords
suppressor
cell hybridoma
specific
gif
immunosuppression
Prior art date
Application number
NO934382A
Other languages
Norwegian (no)
Other versions
NO934382D0 (en
Inventor
Ishizaka Kimishige
Original Assignee
Jolla Inst Allergy Immunolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog filed Critical Jolla Inst Allergy Immunolog
Publication of NO934382D0 publication Critical patent/NO934382D0/en
Publication of NO934382L publication Critical patent/NO934382L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Human antigen-spesifikk glykosyleringsbemmende faktor (GIF) og fremgangsmåte for immunoundertrykkelse av et spesi- fikt immunsvar.Human antigen-specific glycosylation-inhibiting factor (GIF) and method for immunosuppression of a specific immune response.

NO934382A 1991-06-03 1993-12-02 Suppressor T-cell hybridoma NO934382L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70937591A 1991-06-03 1991-06-03
PCT/US1992/004614 WO1992021240A1 (en) 1991-06-03 1992-06-03 Suppressor t-cell hybridoma

Publications (2)

Publication Number Publication Date
NO934382D0 NO934382D0 (en) 1993-12-02
NO934382L true NO934382L (en) 1994-02-02

Family

ID=24849607

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934382A NO934382L (en) 1991-06-03 1993-12-02 Suppressor T-cell hybridoma

Country Status (8)

Country Link
EP (1) EP0591320A4 (en)
JP (1) JPH06508829A (en)
AU (1) AU2161792A (en)
CA (1) CA2103046A1 (en)
FI (1) FI934989A (en)
HU (1) HUT67010A (en)
NO (1) NO934382L (en)
WO (1) WO1992021240A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3578787B2 (en) * 1993-05-14 2004-10-20 ラホヤ インスティチュート フォア アレルギー アンド イムノロジー Method for recombinant production of biologically active polypeptide
WO2014192877A1 (en) * 2013-05-29 2014-12-04 Jsr株式会社 Washing composition, protein purification method, and protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
EP0285405A1 (en) * 1987-03-31 1988-10-05 Schering Biotech Corporation Glycosylation inhibition factors

Also Published As

Publication number Publication date
HU9303380D0 (en) 1994-03-28
EP0591320A4 (en) 1994-11-23
WO1992021240A1 (en) 1992-12-10
FI934989A (en) 1993-12-01
NO934382D0 (en) 1993-12-02
AU2161792A (en) 1993-01-08
EP0591320A1 (en) 1994-04-13
FI934989A0 (en) 1993-11-11
HUT67010A (en) 1995-01-30
JPH06508829A (en) 1994-10-06
CA2103046A1 (en) 1992-12-04

Similar Documents

Publication Publication Date Title
NO885006L (en) PROCEDURE AND APPARATUS FOR MOVEMENT COMPENSATION OF RISKS.
DK0555366T3 (en) Method of bacterial attenuation and vaccine
DK0531048T3 (en) Method of Providing Personalized Telephone Calling Methods
NO932532L (en) Method and Device for Missile Interface Testing
NO882891D0 (en) PROCEDURE AND DEVICE FOR DIAMETER REDUCTION OF RODFORMED BODIES.
NO880081D0 (en) DEVICE AND PROCEDURE FOR REMOTE CONTROL INTRODUCTION OF CEMENTATION PLUGS INTO A BROWN.
NO931244D0 (en) PROCEDURE AND DEVICE FOR INERT GAS PRODUCTION
GB9028118D0 (en) Retaining device of annular member
NO912483L (en) PROCEDURE AND DEVICE FOR PROCESSING AN ANALOG SIGNAL.
NO910277L (en) SYSTEM AND METHOD FOR CONVERSION OF POLLUTANEOUS GAS.
NO142955C (en) PROCEDURE AND APPARATUS FOR THE PROMOTION OF A PROTECTIVE HOLIDAY FOR AN OBJECTS
NO903110L (en) PROCEDURE AND DEVICE FOR STABILIZING SEISMIC ENERGY SOURCES.
EP0666761A4 (en) Stimulation of an antitumor t-cell response using anti-idiotypic antibodies.
DK20391A (en) HONEY POWDER AND METHOD OF PRODUCING THEREOF
NO934382L (en) Suppressor T-cell hybridoma
DK312288D0 (en) PROCEDURE AND EQUIPMENT FOR MECHANICAL ITEM EXTENSION
NO913662D0 (en) PROCEDURE AND DEVICE FOR PREPARATION OF GOVERNMENT GOODS.
NO933794L (en) Method and apparatus for underwater archery
DK0512547T3 (en) Pain-controlling preparation and method of preparation thereof
JPS5597769A (en) Method of and device for talking via plural different telephone sets
DK108990A (en) PIG DYSENTERY PUBLIC VACCINE AND PROCEDURE FOR PREPARING THEREOF
NO874619D0 (en) EQUIPMENT AND EQUIPMENT FOR POSITIONING OF SEALS AND PREPARATIONS.
DE69124565D1 (en) Gas synthesis method and device
NO894634D0 (en) PROCEDURE AND APPARATUS FOR INSTALLATION OF TIGHT-TENSED LINES.
EP0519082A4 (en) Method of teaching palletizing